| Product Name |
Fulvestrant Inhouse Impurity 17 / (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol |
| Product Category | Impurities, Intermediates |
| Sub-Category | Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No | 875573-67-4 |
| Catalog Number | GS.47.FUL.47 |
| Chemical Name/Synonyms | Fulvestrant int3;Fulvestrant Impurity 43;Fulvestrant intermediate N-2;Fulvestrant interMediate N-2(1);Fulvestrant Intermediates--5-1(N-3-1);Fulvestrant intermediate N-3 hydrolysate;7α-(9-Bromononyl)estra-1,3,5(10)-triene-3,17β-diol;(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol;(7α,17β)-7-(9-bromononyl)estra-1,3,5(10)-triene-3,17-diol;(7α,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol |
| Molecular Weight | 477.52 |
| Molecular Formula | C27H41BrO2 |
| Purity | NLT 95 % |
| Applications | It is an impurity of Fulvestrant which is used to treat hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in postmenopausal women. |
| Inventory Status | customized |